Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1977 Sep 1;146(3):641–652. doi: 10.1084/jem.146.3.641

In vitro granulocyte adherence and in vivo margination: two associated complement-dependent functions

J Fehr, HS Jacob
PMCID: PMC2180784  PMID: 894188

Abstract

To study mechanisms and mediators regulating the distribution of intravascular granulocytes between circulating and marginated pools, a human model with extreme transient margination, the neutropenia of continuous flow filtration leukophoresis, was analyzed. Studies in animals demonstrated the existence of a complement (C)-derived granulocytopenia-inducing factor. Thus, autologous plasma, exposed to nylon fibers (NF) of the filtration system, produced an acute selective decrement of circulating granulocytes and monocytes. This phenomenon was blocked by decomplementing plasma, by pretreatment of plasma with EDTA or hydrazine, and by preheating at 56 degrees C, but did occur after recombination of heat-inactivated and hydrazine-treated plasma before NF exposure. Preheating plasma at 50 degrees C did not inhibit the neutropenic response, suggesting involvement of the classical pathway of C activation. Ultrafiltration studies indicated that the NF-provoked neutropenia-inducing factor has a mol wt in the range of 10,000-30,000, and is heat stable (56 degrees C). To analyze the hypothesis that C- induced neutrophil margination might be consequent to increased cell adhesiveness to endothelial surfaces, the role of C in promoting granulocyte adherence was evaluated in vitro. Measured with a plastic Petridish assay, granulocyte adherence was significantly reduced in heat- inactivated (56 degrees C) and hydrazine-treated plasma, but adherence promoting capacity was restored by mixing the two plasmas, or by adding purified C3 to hydrazine-treated plasma. After exposure to activated C, neutrophils showed significantly increased adhesiveness which was maintained when cells were resuspended in heat-inactivated plasma, but progressively lost when resuspended in fresh plasma. On the basis of these results we conclude that granulocyte adhesiveness in vitro and margination in vivo are closely associated, C-dependent phenomena.

Full Text

The Full Text of this article is available as a PDF (883.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ATHENS J. W., HAAB O. P., RAAB S. O., MAUER A. M., ASHENBRUCKER H., CARTWRIGHT G. E., WINTROBE M. M. Leukokinetic studies. IV. The total blood, circulating and marginal granulocyte pools and the granulocyte turnover rate in normal subjects. J Clin Invest. 1961 Jun;40:989–995. doi: 10.1172/JCI104338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bokisch V. A., Dierich M. P., Mūller-Eberhard H. J. Third component of complement (C3): structural properties in relation to functions. Proc Natl Acad Sci U S A. 1975 Jun;72(6):1989–1993. doi: 10.1073/pnas.72.6.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bokisch V. A., Müller-Eberhard H. J., Cochrane C. G. Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum. J Exp Med. 1969 May 1;129(5):1109–1130. doi: 10.1084/jem.129.5.1109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brown D. L. Complement and coagulation. Br J Haematol. 1975 Aug;30(4):377–382. doi: 10.1111/j.1365-2141.1975.tb01851.x. [DOI] [PubMed] [Google Scholar]
  5. Cochrane C. G., Müller-Eberhard H. J., Aikin B. S. Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions. J Immunol. 1970 Jul;105(1):55–69. [PubMed] [Google Scholar]
  6. Colman R. W. Formation of human plasma kinin. N Engl J Med. 1974 Sep 5;291(10):509–515. doi: 10.1056/NEJM197409052911008. [DOI] [PubMed] [Google Scholar]
  7. Conroy M. C., Ozols J., Lepow I. H. Structural features and biologic properties of fragments obtained by limited proteolysis of C3. J Immunol. 1976 Jun;116(6):1682–1687. [PubMed] [Google Scholar]
  8. Craddock P. R., Fehr J., Brigham K. L., Kronenberg R. S., Jacob H. S. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med. 1977 Apr 7;296(14):769–774. doi: 10.1056/NEJM197704072961401. [DOI] [PubMed] [Google Scholar]
  9. Craddock P. R., Fehr J., Dalmasso A. P., Brighan K. L., Jacob H. S. Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest. 1977 May;59(5):879–888. doi: 10.1172/JCI108710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fearon D. T., Austen K. F., Ruddy S. Serum proteins involved in decay and regeneration of cobra venom factor-dependent complement activation. J Immunol. 1973 Dec;111(6):1730–1736. [PubMed] [Google Scholar]
  11. Fearon D. T., Ruddy S., Knostman J. D., Carpenter C. B., Austen K. F. The functional significance of complement. Adv Nephrol Necker Hosp. 1974;4:15–35. [PubMed] [Google Scholar]
  12. Fong J. S., Good R. A. Prevention of the localized and generalized Shwartzman reactions by an anticomplementary agent, cobra venom factor. J Exp Med. 1971 Sep 1;134(3 Pt 1):642–655. doi: 10.1084/jem.134.3.642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gallin J. I., Durocher J. R., Kaplan A. P. Interaction of leukocyte chemotactic factors with the cell surface. I. Chemotactic factor-induced changes in human granulocyte surface charge. J Clin Invest. 1975 May;55(5):967–974. doi: 10.1172/JCI108026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gallin J. I., Wolff S. M. Leucocyte chemotaxis: physiological considerations and abnormalities. Clin Haematol. 1975 Oct;4(3):567–607. [PubMed] [Google Scholar]
  15. Goodkofsky I., Lepow I. H. Functional relationship of factor B in the properdin system to C3 proactivator of human serum. J Immunol. 1971 Oct;107(4):1200–1204. [PubMed] [Google Scholar]
  16. Herzig G. P., Root R. K., Graw R. G., Jr Granulocyte collection by continuous-flow filtration leukapheresis. Blood. 1972 Apr;39(4):554–567. [PubMed] [Google Scholar]
  17. Himmelhoch S. R., Evans W. H., Mage M. G., Peterson E. A. Purification of myeloperoxidases from the bone marrow of the guinea pig. Biochemistry. 1969 Mar;8(3):914–921. doi: 10.1021/bi00831a022. [DOI] [PubMed] [Google Scholar]
  18. Hugli T. E. Human anaphylatoxin (C3a) from the third component of complement. Primary structure. J Biol Chem. 1975 Nov 10;250(21):8293–8301. [PubMed] [Google Scholar]
  19. Jensen D. P., Brubaker L. H., Nolph K. D., Johnson C. A., Nothum R. J. Hemodialysis coil-induced transient neutropenia and overshoot neutrophilia in normal man. Blood. 1973 Mar;41(3):399–408. [PubMed] [Google Scholar]
  20. Keller H. U., Hess M. W., Cottier H. Inhibiting effects of human plasma and serum on neutrophil random migration and chemotaxis. Blood. 1974 Dec;44(6):843–848. [PubMed] [Google Scholar]
  21. Keller H. U., Hess M. W., Cottier H. Physiology of chemotaxis and random motility. Semin Hematol. 1975 Jan;12(1):47–57. [PubMed] [Google Scholar]
  22. Lachmann P. J., Halbwachs L. The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation. Clin Exp Immunol. 1975 Jul;21(1):109–114. [PMC free article] [PubMed] [Google Scholar]
  23. Lundquist I., Josefsson J. O. Sensitive method for determination of peroxidase activity in tissue by means of coupled oxidation reaction. Anal Biochem. 1971 Jun;41(2):567–577. doi: 10.1016/0003-2697(71)90179-5. [DOI] [PubMed] [Google Scholar]
  24. May J. E., Frank M. M. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway. J Immunol. 1973 Dec;111(6):1668–1676. [PubMed] [Google Scholar]
  25. Müller-Eberhard H. J., Götze O. C3 proactivator convertase and its mode of action. J Exp Med. 1972 Apr 1;135(4):1003–1008. doi: 10.1084/jem.135.4.1003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Nelson R. A., Jr, Jensen J., Gigli I., Tamura N. Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum. Immunochemistry. 1966 Mar;3(2):111–135. doi: 10.1016/0019-2791(66)90292-8. [DOI] [PubMed] [Google Scholar]
  27. Nicol P. A., Lachmann P. J. The alternate pathway of complement activation. The role of C3 and its inactivator (KAF). Immunology. 1973 Feb;24(2):259–275. [PMC free article] [PubMed] [Google Scholar]
  28. Perrin L. H., Shiraishi S., Stroud R. M., Lambert P. H. Detection and quantitation in plasma and synovial fluid of a fragment of human C4 with alpha mobility generated during the activation of the complement system. J Immunol. 1975 Jul;115(1):32–35. [PubMed] [Google Scholar]
  29. Pfueller S. L., Lüscher E. F. Studies of the mechanisms of the human platelet release reaction induced by immunologic stimuli. II. The effects of zymosan. J Immunol. 1974 Mar;112(3):1211–1218. [PubMed] [Google Scholar]
  30. Ruddy S., Gigli I., Austen K. F. The complement system of man. I. N Engl J Med. 1972 Sep 7;287(10):489–495. doi: 10.1056/NEJM197209072871005. [DOI] [PubMed] [Google Scholar]
  31. Schiffer C. A., Aisner J., Wiernik P. H. Transient neutropenia induced by transfusion of blood exposed to nylon fiber filters. Blood. 1975 Jan;45(1):141–146. [PubMed] [Google Scholar]
  32. Stossel T. P. Phagocytosis: recognition and ingestion. Semin Hematol. 1975 Jan;12(1):83–116. [PubMed] [Google Scholar]
  33. Toren M., Goffinet J. A., Kaplow L. S. Pulmonary bed sequestration of neutrophils during hemodialysis. Blood. 1970 Sep;36(3):337–340. [PubMed] [Google Scholar]
  34. Vallota E. H., Müller-Eberhard H. J. Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator. J Exp Med. 1973 May 1;137(5):1109–1123. doi: 10.1084/jem.137.5.1109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Ward P. A. Leukotaxis and leukotactic disorders. A review. Am J Pathol. 1974 Dec;77(3):520–538. [PMC free article] [PubMed] [Google Scholar]
  36. Weiss L. Biophysical aspects of initial cell interactions with solid surfaces. Fed Proc. 1971 Sep-Oct;30(5):1649–1657. [PubMed] [Google Scholar]
  37. Zucker M. B., Grant R. A., Alper C. A., Goodkofsky I., Lepow I. H. Requirement for complement components and fibrinogen in the zymosan-induced release reaction of human blood platelets. J Immunol. 1974 Dec;113(6):1744–1751. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES